These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18655522

  • 21. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R, Martin DD, Schönau E, Ranke MB.
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [Abstract] [Full Text] [Related]

  • 22. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.
    Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P, International Small for Gestational Age Advisory Board.
    Pediatrics; 2003 Jun; 111(6 Pt 1):1253-61. PubMed ID: 12777538
    [Abstract] [Full Text] [Related]

  • 23. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E, Kriström B, Jonsson B, Albertsson-Wikland K, study group.
    BMC Endocr Disord; 2015 Dec 18; 15():84. PubMed ID: 26682747
    [Abstract] [Full Text] [Related]

  • 24. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies.
    de Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Löfström A, Butenandt O, Chaussain JL.
    Acta Paediatr Suppl; 1996 Oct 18; 417():27-31. PubMed ID: 9055905
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W, Bannink E, van Dijk M, Willemsen R, van der Kaay D, de Ridder M, Hokken-Koelega A.
    Horm Res; 2008 Oct 18; 69(2):89-98. PubMed ID: 18059089
    [Abstract] [Full Text] [Related]

  • 27. Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children.
    Dörr HG, Bettendorf M, Hauffa BP, Mehls O, Rohrer T, Stahnke N, Pfäffle R, Ranke MB, German KIGS Group.
    Clin Endocrinol (Oxf); 2011 Nov 18; 75(5):656-60. PubMed ID: 21623854
    [Abstract] [Full Text] [Related]

  • 28. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis.
    Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP, Saenger P.
    Horm Res; 2006 Nov 18; 65 Suppl 3():153-9. PubMed ID: 16612129
    [Abstract] [Full Text] [Related]

  • 29. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
    Labarta JI, de Arriba A, Ferrer M, Loranca M, Martos JM, Rodríguez A, Samaniego ML, Sánchez-Cenizo L.
    J Pediatr Endocrinol Metab; 2020 Jul 28; 33(7):923-932. PubMed ID: 32623373
    [Abstract] [Full Text] [Related]

  • 30. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LM, Carlsson B, Albertsson-Wikland K.
    Eur J Endocrinol; 1997 Oct 28; 137(4):387-95. PubMed ID: 9368507
    [Abstract] [Full Text] [Related]

  • 31. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA, Stijnen T, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2008 Feb 28; 93(2):477-83. PubMed ID: 18000093
    [Abstract] [Full Text] [Related]

  • 32. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2000 Oct 28; 85(10):3786-92. PubMed ID: 11061539
    [Abstract] [Full Text] [Related]

  • 33. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW, Willemsen RH, van der Kaay DC, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Apr 28; 70(4):582-7. PubMed ID: 19067725
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone treatment in short children born prematurely--data from KIGS.
    Boguszewski MC, Karlsson H, Wollmann HA, Wilton P, Dahlgren J.
    J Clin Endocrinol Metab; 2011 Jun 28; 96(6):1687-94. PubMed ID: 21430029
    [Abstract] [Full Text] [Related]

  • 35. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA, Longui CA, Kochi C, Arruda M, Faria CD, Calliari LE, Monte O, Pachi PR, Saenger P.
    Horm Res; 2009 Jun 28; 72(5):275-80. PubMed ID: 19844113
    [Abstract] [Full Text] [Related]

  • 36. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE.
    Clin Endocrinol (Oxf); 2000 Sep 28; 53(3):329-36. PubMed ID: 10971450
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ, van der Kaay DC, de Ridder MA, Bakker-van Waarde WM, van der Hulst FJ, Mulder JC, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Sulkers EJ, Westerlaken C, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2012 Nov 28; 97(11):4096-105. PubMed ID: 22904179
    [Abstract] [Full Text] [Related]

  • 39. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 28; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.